Junbo Ge Selected Research

Transplantation

7/2021	Alda-1 treatment promotes the therapeutic effect of mitochondrial transplantation for myocardial ischemia-reperfusion injury.
9/2020	SIRT5 deficiency enhances the proliferative and therapeutic capacities of adipose-derived mesenchymal stem cells via metabolic switching.
1/2019	Insights from Exercise-induced Cardioprotection-from Clinical Application to Basic Research.
8/2014	Elevated pulmonary artery pressure predicts poor outcome after cardiac resynchronization therapy.
4/2014	Aldehyde dehydrogenase-2 is a host factor required for effective bone marrow mesenchymal stem cell therapy.
2/2014	Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.
12/2012	High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species.
1/2012	Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats.
6/2010	Efficacy and safety of intracoronary autologous bone marrow-derived cell transplantation in patients with acute myocardial infarction: insights from randomized controlled trials with 12 or more months follow-up.
8/2009	Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junbo Ge Research Topics

Disease

116	Myocardial Infarction 11/2022 - 01/2005
80	Heart Failure 12/2022 - 05/2006
57	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 02/2005
40	Thrombosis (Thrombus) 01/2023 - 08/2005
39	Atherosclerosis 03/2022 - 09/2004
34	Fibrosis (Cirrhosis) 06/2022 - 05/2011
32	Hemorrhage 01/2022 - 02/2010
31	Inflammation (Inflammations) 01/2023 - 12/2006
29	Cardiomegaly (Heart Hypertrophy) 01/2022 - 02/2008
28	Infarction (Infarctions) 06/2022 - 01/2004
27	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 02/2005
27	ST Elevation Myocardial Infarction 06/2022 - 05/2007
25	Hypoxia (Hypoxemia) 01/2022 - 02/2011
21	Ischemia 03/2022 - 04/2010
21	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2004
21	Acute Coronary Syndrome 01/2022 - 06/2009
17	Hypertension (High Blood Pressure) 05/2022 - 12/2010
17	Stroke (Strokes) 01/2022 - 08/2005
17	Death (Near-Death Experience) 01/2022 - 01/2010
16	Reperfusion Injury 01/2022 - 06/2012
16	Coronary Disease (Coronary Heart Disease) 01/2022 - 06/2009
15	Atrial Fibrillation 06/2022 - 02/2002
15	Hypertrophy 01/2022 - 05/2011
13	Heart Diseases (Heart Disease) 01/2022 - 01/2013
13	Pathologic Constriction (Stenosis) 01/2021 - 02/2007
12	Myocarditis (Carditis) 01/2022 - 04/2008
11	Infections 01/2022 - 07/2003
11	Cardiomyopathies (Cardiomyopathy) 01/2022 - 05/2011
10	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2022 - 05/2006
9	Ventricular Remodeling 01/2022 - 07/2005
8	Type 2 Diabetes Mellitus (MODY) 12/2022 - 11/2017
8	Atherosclerotic Plaque (Atheroma) 01/2022 - 11/2004
7	Aortic Valve Insufficiency (Aortic Regurgitation) 06/2022 - 11/2012
7	Diabetes Mellitus 01/2022 - 01/2010
7	Necrosis 01/2022 - 01/2010
6	Hyperplasia 01/2023 - 12/2006
6	Rupture 01/2022 - 06/2011
5	Ischemic Stroke 11/2022 - 04/2015
5	Pathologic Processes 06/2022 - 01/2014
5	Hyperlipidemias (Hyperlipidemia) 01/2020 - 11/2004

Drug/Important Bio-Agent (IBA)

25	omega-Chloroacetophenone (Mace)IBA 03/2022 - 02/2005
21	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2006
17	oxidized low density lipoproteinIBA 01/2022 - 12/2004
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
13	Angiotensin IIIBA 01/2022 - 02/2008
12	Pharmaceutical PreparationsIBA 06/2022 - 09/2012
12	CytokinesIBA 05/2022 - 10/2012
12	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 07/2009
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2021 - 04/2010
11	Sirolimus (Rapamycin)FDA Link 01/2023 - 05/2007
11	LipidsIBA 11/2022 - 11/2004
11	Therapeutic UsesIBA 01/2022 - 01/2004
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2004
10	Apolipoproteins E (ApoE)IBA 01/2022 - 11/2012
9	Messenger RNA (mRNA)IBA 06/2022 - 05/2006
9	Aldehyde DehydrogenaseIBA 01/2022 - 01/2013
9	CollagenIBA 01/2022 - 11/2006
9	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 07/2009
8	Troponin T (Troponin T1)IBA 06/2022 - 01/2010
8	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 08/2015
8	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 05/2013
7	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 12/2018
7	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2012
7	salicylhydroxamic acid (SHAM)IBA 01/2020 - 11/2012
7	PolymersIBA 01/2020 - 06/2012
7	Phenobarbital (Luminal)FDA Link 12/2019 - 02/2005
6	Circular RNAIBA 06/2022 - 01/2020
6	Clopidogrel (Plavix)FDA Link 01/2022 - 09/2010
6	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 12/2004
6	CholesterolIBA 01/2021 - 11/2004
6	LDL CholesterolIBA 01/2021 - 05/2010
6	Mitochondrial Aldehyde DehydrogenaseIBA 01/2021 - 09/2014
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 02/2010
6	Valsartan (Vals)FDA Link 01/2020 - 12/2010
6	qiliqiangxinIBA 01/2020 - 03/2012
6	Type 1 Angiotensin ReceptorIBA 08/2015 - 06/2010
5	HMGB1 Protein (HMG1)IBA 01/2022 - 03/2016
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
5	InflammasomesIBA 12/2021 - 01/2017
5	Everolimus FDA Link 11/2021 - 02/2011
5	paragonIBA 01/2021 - 01/2017
5	TicagrelorIBA 01/2021 - 10/2014
5	evolocumabIBA 01/2021 - 09/2018
5	EnzymesIBA 01/2021 - 11/2010
5	MetalsIBA 01/2021 - 02/2005
5	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020 - 01/2017
5	Atorvastatin (Lipitor)FDA Link 01/2019 - 10/2011

Therapy/Procedure

61	Percutaneous Coronary Intervention 10/2022 - 05/2007
59	Therapeutics 12/2022 - 01/2004
48	Stents 01/2023 - 02/2005
16	Transplantation 07/2021 - 01/2004
14	Drug-Eluting Stents 01/2022 - 01/2010
12	Ligation 01/2021 - 07/2005
11	Cardiac Resynchronization Therapy 01/2022 - 10/2011
8	Catheters 06/2022 - 06/2002
7	Denervation 01/2021 - 01/2014
6	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 04/2008
5	Transcatheter Aortic Valve Replacement 06/2022 - 04/2012
5	Patient Readmission 01/2021 - 10/2011
5	Secondary Prevention 11/2019 - 01/2012